These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 11207785

  • 1. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN, Penney S, Buckley DJ.
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 3. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD, Li M, Tsao J, Zhou R, Wu YW, Sankar R, Wu JY, Hussain SA.
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [Abstract] [Full Text] [Related]

  • 4. Vigabatrin: 2008 update.
    Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [Abstract] [Full Text] [Related]

  • 5. Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making.
    Paul SR, Krauss GL, Miller NR, Medura MT, Miller TA, Johnson MA.
    Epilepsia; 2001 Apr; 42(4):525-30. PubMed ID: 11440348
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S, Uematsu M, Sato H, Numata-Uematsu Y, Nakayama T, Kiluchi A, Kobayashi T, Hino-Fukuyo N, Kure S.
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [Abstract] [Full Text] [Related]

  • 7. Visual field constriction in 91 Finnish children treated with vigabatrin.
    Vanhatalo S, Nousiainen I, Eriksson K, Rantala H, Vainionpää L, Mustonen K, Aärimaa T, Alen R, Aine MR, Byring R, Hirvasniemi A, Nuutila A, Walden T, Ritanen-Mohammed UM, Karttunen-Lewandowski P, Pohjola LM, Kaksonen S, Jurvelin P, Granström ML.
    Epilepsia; 2002 Jul; 43(7):748-56. PubMed ID: 12102679
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and tolerability of vigabatrin in West syndrome].
    Moraes MH, Montenegro MA, Franzon RC, Avila JO, Guerreiro MM.
    Arq Neuropsiquiatr; 2005 Jun; 63(2B):469-73. PubMed ID: 16059600
    [Abstract] [Full Text] [Related]

  • 9. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E, Jonsson H, Lappi M.
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [Abstract] [Full Text] [Related]

  • 10. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, Dutton GN, Brodie MJ.
    Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
    [Abstract] [Full Text] [Related]

  • 11. Vigabatrin therapy in infantile spasms.
    Kankirawatana P, Raksadawan N, Balangkura K.
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [Abstract] [Full Text] [Related]

  • 12. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I, Chiron C, Dumas C, Mumford J, Dulac O.
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [Abstract] [Full Text] [Related]

  • 13. Vigabatrin - new data on indications and safety in paediatric epilepsy.
    Golec W, Sołowiej E, Strzelecka J, Jurkiewicz E, Jóźwiak S.
    Neurol Neurochir Pol; 2021 Feb; 55(5):429-439. PubMed ID: 34541635
    [Abstract] [Full Text] [Related]

  • 14. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B.
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [Abstract] [Full Text] [Related]

  • 15. Vigabatrin and visual field defects in pediatric epilepsy patients.
    You SJ, Ahn H, Ko TS.
    J Korean Med Sci; 2006 Aug; 21(4):728-32. PubMed ID: 16891821
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vigabatrin and epilepsy: lessons learned.
    Wild JM, Ahn HS, Baulac M, Bursztyn J, Chiron C, Gandolfo E, Safran AB, Schiefer U, Perucca E.
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [Abstract] [Full Text] [Related]

  • 18. Vigabatrin in pediatric patients with refractory epilepsy.
    Turanli G, Celebi A, Yalnizoğlu D, Topçu M, Topaloğlu H, Banu A, Aysun S.
    Turk J Pediatr; 2006 Jul; 48(1):25-30. PubMed ID: 16562782
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
    Garaizar C, Martínez-González MJ, Fernández-Cuesta MA, Prats JM.
    Rev Neurol; 2006 Jul; 29(3):201-7. PubMed ID: 10797902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.